Get started
CIPHER PHARMACEUTICALS INCCIPHER PHARMACEUTICALS INCCIPHER PHARMACEUTICALS INC

CIPHER PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

CPH chart


Full chart

CPH upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪317.61 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
19.47
Basic EPS (TTM)
0.64 CAD
Net income (FY)
‪15.82 M‬ CAD
Revenue (FY)
‪45.71 M‬ CAD
Shares float
‪14.85 M‬
Beta (1Y)
−0.13

About CIPHER PHARMACEUTICALS INC


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Craig Mull
Website
cipherpharma.com
Headquarters
Mississauga
Founded
2000
FIGI
BBG000BSKPS7
Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. It offers dermatology products, hospital acute care products, out-licensed products, and specialty medicine. The company was founded on January 9, 2004 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CPH news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CPH.

Frequently Asked Questions


The current price of CPH is 12.39 CAD — it has decreased by −0.081% in the past 24 hours. Watch CIPHER PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange CIPHER PHARMACEUTICALS INC stocks are traded under the ticker CPH.
CPH stock has risen by 3.25% compared to the previous week, the month change is a −3.58% fall, over the last year CIPHER PHARMACEUTICALS INC has showed a 45.42% increase.
We've gathered analysts' opinions on CIPHER PHARMACEUTICALS INC future price: according to them, CPH price has a max estimate of 18.48 CAD and a min estimate of 12.51 CAD. Watch CPH chart and read a more detailed CIPHER PHARMACEUTICALS INC stock forecast: see what analysts think of CIPHER PHARMACEUTICALS INC and suggest that you do with its stocks.
CPH reached its all-time high on Aug 29, 2024 with the price of 19.69 CAD, and its all-time low was 0.26 CAD and was reached on Oct 29, 2008. View more price dynamics on CPH chart.
See other stocks reaching their highest and lowest prices.
CPH stock is 2.98% volatile and has beta coefficient of −0.13. Track CIPHER PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is CIPHER PHARMACEUTICALS INC there?
Today CIPHER PHARMACEUTICALS INC has the market capitalization of ‪317.61 M‬, it has increased by 7.88% over the last week.
Yes, you can track CIPHER PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
CIPHER PHARMACEUTICALS INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
CPH earnings for the last quarter are 0.19 CAD per share, whereas the estimation was 0.27 CAD resulting in a −31.58% surprise. The estimated earnings for the next quarter are 0.15 CAD per share. See more details about CIPHER PHARMACEUTICALS INC earnings.
CIPHER PHARMACEUTICALS INC revenue for the last quarter amounts to ‪17.01 M‬ CAD, despite the estimated figure of ‪16.93 M‬ CAD. In the next quarter, revenue is expected to reach ‪17.21 M‬ CAD.
CPH net income for the last quarter is ‪4.68 M‬ CAD, while the quarter before that showed ‪386.00 K‬ CAD of net income which accounts for ‪1.11 K‬% change. Track more CIPHER PHARMACEUTICALS INC financial stats to get the full picture.
No, CPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CIPHER PHARMACEUTICALS INC EBITDA is ‪12.47 M‬ CAD, and current EBITDA margin is 27.43%. See more stats in CIPHER PHARMACEUTICALS INC financial statements.
Like other stocks, CPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CIPHER PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CIPHER PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CIPHER PHARMACEUTICALS INC stock shows the buy signal. See more of CIPHER PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.